About AbbVie
AbbVies mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on peoples lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, womens health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.
The BioProcess Development Department at the AbbVie Bioresearch Center in Worcester, MA is seeking a highly motivated and experienced Scientist to join the CHO Cell Line Development team, working collaboratively with Drug Discovery teams to advance the AbbVie biologics pipeline. The scientist should have in-depth experience in molecular biology, including cloning, NGS and Sanger sequencing/analysis, gene editing and genetic characterization of cell lines used in the biopharmaceutical industry. Expertise in the glycosylation of biotherapeutics is also highly desirable. The scientist will be responsible for the expression vector design and optimization, CHO cell line development as well as genetic characterization of cell lines and cell banks in support of CHO cell line development.
Key Responsibilities Include:
* Next Generation Sequencing (NGS) and Sanger sequencing, RNA-Seq
* Lead and coordinate design, construction and quality control of plasmid DNA
* Develop edited cell lines with favorable manufacturing characteristics
* Develop strategies to optimize cell line glycosylation
* Develop and/or characterize highly-productive stable CHO cell lines suitable for cGMP biotherapeutic manufacturing within project timelines
* Genetic characterization of cell lines for cGMP manufacturing
* Author and review technical reports to support regulatory filing
* Effectively organize and communicate research progress and planned activities through oral and written presentations
* Maintain a high level of productivity in the lab, with clear and accurate documentation of experiments
* Contribute to our team performance and process improvement in a climate of scientific rigor, working collaboratively on projects across multiple BioProcess Development groups
* Demonstrate scientific initiative and creative thinking in achieving project goals and implementing technology innovations. Seek out new information and opportunities to advance our technologies
* Understand and enforce corporate standards regarding code of conduct, documentation, safety, appropriate handling of materials, and GxP compliance
Qualifications
Qualifications
Basic:
* Ph.D. in Molecular Biology with 0-3 years of relevant experience, M.S. degree in Molecular Biology with 3-10 years of relevant experience in the biopharmaceutical industry, or Bachelor's Degree with more than 10 years of experience in the biopharmaceutical industry
* Enable cGMP biotherapeutics manufacturing and associated areas of expertise (e.g., cell and molecular biology, genetic characterization, cell line development, gene editing, process development, recombinant protein production)
* Excellent interpersonal and communication skills. Strong scientific curiosity with a passion for problem-solving and optimization
* Self-motivated with excellent attention to detail and ability to multi-task. Strong organizational, planning and trouble-shooting skills
* Ability to work effectively in a highly collaborative and dynamic environment
Preferred:
* Proven track record in one or more of the following: CHO cell line development, cell line genetic characterization, vector construction, glycosylation, gene editing
Key Leadership Competencies:
* Builds strong relationships with peers and cross-functional team members
* Learns quickly, grasps the 'essence' and can change the course quickly where indicated
* Raises the bar and is never satisfied with the status quo
* Embraces a learning environment, open to suggestions and experimentation for continuous improvement
Significant Work Activities
N/A
Travel
No
Job Type
Experienced
Schedule
Full-time
Job Level Code
IC
Equal Employment Opportunity
At AbbVie, we value bringing together individuals from diverse backgrounds to develop new and innovative solutions for patients. As an equal opportunity employer we do not discriminate on the basis of race, color, religion, national origin, age, sex (including pregnancy), physical or mental disability, medical condition, genetic information gender identity or expression, sexual orientation, marital status, protected veteran status, or any other legally protected characteristic.
Chicago, IL
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products in the United States, Japan, Germany, Canada, Italy, Spain, the Netherlands, the United Kingdom, Brazil, and internationally. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), mantle cell lymphoma, waldenström’s macroglobulinemia, marginal zone lymphoma, and chronic graft versus host disease; VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; VIEKIRA PAK, an interferon-free therapy to treat adults with genotype 1 chronic hepatitis C virus (HCV); TECHNIVIE to treat adults with genotype 4 HCV infection; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection.
It also provides KALETRA, an anti-human immunodeficiency virus (HIV)-1 medicine used with other anti-HIV-1 medications to maintain viral suppression in HIV-1 patients; NORVIR, a protease inhibitor indicated in combination with other antiretroviral agents to treat HIV-1; and SYNAGIS to prevent respiratory syncytial virus infection at-risk infants. In addition, the company offers AndroGel, a testosterone replacement therapy for males; CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid to treat hypothyroidism; and Lupron to treat prostate cancer, endometriosis, and central precocious puberty, as well as anemia.
Further, it provides Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson’s disease; Sevoflurane, an anesthesia product; and ORILISSA, a non-peptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain. It has collaborations with Alector, Inc.; Janssen Biotech, Inc.; Galapagos; Bristol-Myers Squibb Company; and Calico Life Sciences LLC. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.